| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Propanc Biopharma, Inc. (NASDAQ:PPCB) ("Propanc" or the "Company"), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced a plan to acquire $100 million of Ethereum over the next 12 months. The asset purchase of Ethereum will enhance a multi-faceted corporate strategy of cryptocurrency exposure, pharmaceutical drug development and asset acquisition within the Company's key focus area of biotechnology to improve human health and society. The strategic purchase of Ethereum provides a significant opportunity to diversify assets, realize potential value, address current cash flow needs of the Company during the pre-revenue stage and help to accelerate future revenue growth potential by investing into the Company's core assets to commercialization, whilst also identifying new opportunities to expand its IP portfolio through acquisition.
The cumulative gains for Bitcoin since 2011 are more than 20,000,000%, significantly more than the Nasdaq 100 and US Large Caps, which had returns of 541% and 282%, respectively (https://www.bitcoinmagazinepro.com). On an annualized scale, Bitcoin returned 230% - 10x higher than the Nasdaq 100, the second-best performing asset class (https://wazoplus.com). During the same period, large U.S. Caps recorded an annualized return of 14%, high-yield bonds gained 5.4%, and gold returned 1.5% (https://www.bitcoinmagazinepro.com). All compelling reasons to consider an asset diversification strategy to accelerate growth, address potential cash flow issues on the path to commercialization of the Company's core IP assets and at the same time deliver potential short-term and long-term value for shareholders. Compared to traditional investments, Ethereum's 5-year return has been significantly higher as well (https://tickeron.com):
Ethereum vs. traditional assets (approx. 5-year returns)
Posted In: PPCB
